7wireVentures January 8, 2025
Combined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment
Transcarent’s Generative AI WayFinding and care experiences combined with Accolade’s Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of ‘One Place for Health and Care’
Accolade shareholders to receive $7.03 per share in cash
San Francisco, CA and Seattle, WA January 8, 2025 – Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care, announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total equity value of approximately...
Today's Sponsors
Today's Sponsor